• Home
  • Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease.

Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease.

Author List
Melisko ME, Assefa M, Hwang J, DeLuca A, Park JW, Rugo HS
Publication
Breast cancer research and treatment
Publication ID (Profile URL)
https://researcherprofiles.org/profile/57843654
Publication Year
2019
PubMed ID
31172405
Publication Title
Melisko ME, Assefa M, Hwang J, DeLuca A, Park JW, Rugo HS. Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease. Breast Cancer Res Treat. 2019 Sep; 177(2):401-408.